Novosti
|
This journal is indexed in Scopus |
---|
Year 2023 Vol. 31 No 1
SCIENTIFIC PUBLICATIONS
S.G. GAVRILOV, I.S. LEBEDEV, A.V. VASILIEV, N.YU. MISHAKINA
RATIONALE OF VENOUS OBSTRUCTION STENTING
Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow,
Russian Federation
Objective. The aim of this study is to substantiate the expediency of using stenting in patients with chronic venous obstruction, based on literature data and real clinical practice.
Methods. A systematic search of current literature on the application of various stents in the treatment of chronic thrombotic and non-thrombotic obstruction of the iliac veins was conducted by browsing the Pubmed, MEDLINE è Google Scholar.
In addition to clinical efficacy, economic aspects of the application of venous stenting in the treatment of chronic venous obstruction have been studied. Clinical observations are presented demonstrating the possibilities of iliac vein stenting in patients with post-thrombotic disease, a combination of May-Turner syndromes and pelvic congestion syndrome.
Results. Currently, both classical and special venous stents are used for stenting of large veins. The latter have greater flexibility and radial strength, and their use is not accompanied by such complications as stent occlusion of the contralateral common iliac vein and conical narrowing of the ends of the stent. The literature data indicate the high efficiency of stenting in restoration of the iliac vein lumen in thrombotic and non-thrombotic obstructions of the iliac veins, and stent patency ranges from 79 to 100% within 1-3 years. The authors report on the relief of edematous and pain syndromes, and healing of trophic ulcers in 70-100% of patients. Studies comparing the cost of venous stenting and standard conservative treatment indicate that the use of endovascular intervention is accompanied by a significant reduction in the economic costs of the treatment, a reduction of expenditures of a medical institution, and a decrease in the period of temporary disability among patients. Clinical observations presented in the study are based on the real clinical practice of the authors of this work and confirm the literature data.
Conclusion. The application of venous stenting is an effective and safe method of restoring the patency of the main veins, which can relieve the clinical manifestations of chronic venous insufficiency and pelvic venous congestion syndrome. This method is also accompanied by a decrease in economic costs in the treatment of patients with chronic venous obstructions.
- Jayaraj A, Raju S. Iliocaval Venous Obstruction. In: Sidawy AN, Perler BA, eds. Rutherford’s vascular surgery and endovascular therapy. Philadelphia, PA: Elsevier; 2019. ð. 6899-932.
- Rognoni C, Lugli M, Maleti O, Tarricone R. Venous stenting for patients with outflow obstruction and leg ulcers: cost-effectiveness and budget impact analyses. J Comp Eff Res. 2020 Jul;9(10):705-20. doi: 10.2217/cer-2020-0030
- Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007 Nov;46(5):979-90. doi: 10.1016/j.jvs.2007.06.046
- Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg. 2011 Mar;53(3):706-12. doi: 10.1016/j.jvs.2010.09.011
- Raju S. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013 Apr;57(4):1163-69. doi: 10.1016/j.jvs.2012.11.084
- Mickley V, Friedrich JM, Hutschenreiter S, Sunder-Plassmann L. Long-term results of percutaneous transluminal angioplasty and stent implantation in venous stenoses following transfemoral thrombectomy. Vasa. 1993;22(1):44-52.
- Zollikofer CL, Schoch E, Stuckmann G, Espinosa N, Stiefel M. Percutaneous transluminal treatment of stenoses and obstructions in the venous system using vascular endoprostheses (stents). Schweiz Med Wochenschr. 1994 Jun 11;124(23):995-1009. [Article in German]
- Williams ZF, Dillavou ED. A systematic review of venous stents for iliac and venacaval occlusive disease. J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):145-153. doi: 10.1016/j.jvsv.2019.08.015
- Majeed GM, Lodhia K, Carter J, Kingdon J, Morris RI, Gwozdz A, Saratzis A, Saha P. A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents. J Endovasc Ther. 2022 Jun;29(3):478-492. doi: 10.1177/15266028211057085
- Shamimi-Noori SM, Clark TWI. Venous Stents: Current Status and Future Directions. Tech Vasc Interv Radiol. 2018 Jun;21(2):113-16. doi: 10.1053/j.tvir.2018.03.007
- Jayaraj A, Raju S. The venous stent: Is it primetime yet? In: Chaar CI, ed. Current management of venous diseases. Springer, Cham; 2018. ð. 489-96. doi: 10.1007/978-3-319-65226-9_37
- Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg. 1995 Feb;21(2):307-12; discussion 313. doi: 10.1016/s0741-5214(95)70271-7
- Neglén P, Thrasher TL, Raju S. Venous outflow obstruction: An underestimated contributor to chronic venous disease. J Vasc Surg. 2003 Nov;38(5):879-85. doi: 10.1016/s0741-5214(03)01020-6
- Raju S. Treatment of iliac-caval outflow obstruction. Semin Vasc Surg. 2015 Mar;28(1):47-53. doi: 10.1053/j.semvascsurg.2015.07.001
- Dabir D, Feisst A, Thomas D, Luetkens JA, Meyer C, Kardulovic A, Menne M, Steinseifer U, Schild HH, Kuetting DLR. Physical Properties of Venous Stents: An Experimental Comparison. Cardiovasc Intervent Radiol. 2018 Jun;41(6):942-50. doi: 10.1007/s00270-018-1916-1
- Sayed MH, Salem M, Desai KR, O’Sullivan GJ, Black SA. A review of the incidence, outcome, and management of venous stent migration. J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):482-90. doi: 10.1016/j.jvsv.2021.07.015
- Badesha AS, Bains PRS, Bains BRS, Khan T. A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):267-82.e4. doi: 10.1016/j.jvsv.2021.04.014
- Raju S, Darcey R, Neglén P. Unexpected major role for venous stenting in deep reflux disease. J Vasc Surg. 2010 Feb;51(2):401-8; discussion 408. doi: 10.1016/j.jvs.2009.08.032
- Dake MD, O’Sullivan G, Shammas NW, Lichtenberg M, Mwipatayi BP, Settlage RA; VERNACULAR Trial Investigators. Three-Year Results from the Venovo Venous Stent Study for the Treatment of Iliac and Femoral Vein Obstruction. Cardiovasc Intervent Radiol. 2021 Dec;44(12):1918-29. doi: 10.1007/s00270-021-02975-2
- Razavi M, Marston W, Black S, Bentley D, Neglén P. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):192-200. doi: 10.1016/j.jvsv.2017.10.014
- Gloviczki P, Kalra M, Duncan AA, Oderich GS, Vrtiska TJ, Bower TC. Open and hybrid deep vein reconstructions: to do or not to do? Phlebology. 2012 Mar;27 Suppl 1:103-6. doi: 10.1258/phleb.2012.012s29
- Gavrilov SG, Vasilyev AV, Krasavin GV, Moskalenko YP, Mishakina NY. Endovascular interventions in the treatment of pelvic congestion syndrome caused by May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1049-57. doi: 10.1016/j.jvsv.2020.02.012
- van Vuuren TMAJ, Kurstjens RLM, Wittens CHA, van Laanen JHH, de Graaf R. Illusory Angiographic Signs of Significant Iliac Vein Compression in Healthy Volunteers. Eur J Vasc Endovasc Surg. 2018 Dec;56(6):874-79. doi: 10.1016/j.ejvs.2018.07.022
- Jayaraj A, Powell T, Raju S. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1408-15. doi: 10.1016/j.jvsv.2021.05.008
- Akesson H, Brudin L, Dahlström JA, Eklöf B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990 Feb;4(1):43-48. doi: 10.1016/s0950-821x(05)80037-4
- Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 200 4 Jan;239(1):118-26. doi: 10.1097/01.sla.0000103067.10695.74
- Jayaraj A, Noel C, Kuykendall R, Raju S. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting. J Vasc Surg Venous Lymphat Disord. 2021 Mar;9(2):393-400.e2. doi: 10.1016/j.jvsv.2020.08.020
- Rizvi SA, Ascher E, Hingorani A, Marks N. Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):457-63. doi: 10.1016/j.jvsv.2018.02.004
- Ye K, Shi H, Yin M, Qin J, Yang X, Liu X, Jiang M, Lu X. Treatment of Femoral Vein Obstruction Concomitant with Iliofemoral Stenting in Patients with Severe Post-thrombotic Syndrome. Eur J Vasc Endovasc Surg. 2018 Feb;55(2):222-28. doi: 10.1016/j.ejvs.2017.11.029
- Gianesini S, Obi A, Onida S, Baccellieri D, Bissacco D, Borsuk D, Campisi C, Campisi CC, Cavezzi A, Chi YW, Chunga J, Corda D, Crippa A, Davies A, De Maeseneer M, Diaz J, Ferreira J, Gasparis A, Intriago E, Jawien A, Jindal R, Kabnick L, Latorre A, Lee BB, Liew NC, Lurie F, Meissner M, Menegatti E, Molteni M, Morrison N, Mosti G, Narayanan S, Pannier F, Parsi K, Partsch H, Rabe E, Raffetto J, Raymond-Martimbeau P, Rockson S, Rosukhovski D, Santiago FR, Schul A, Schul M, Shaydakov E, Sibilla MG, Tessari L, Tomaselli F, Urbanek T, van Rijn MJ, Wakefield T, Wittens C, Zamboni P, Bottini O. Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23-25 January 2019. Phlebology. 2019 Sep;34(1 Suppl):4-66. doi: 10.1177/0268355519870690
- Gagne PJ, Gagne N, Kucher T, Thompson M, Bentley D. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):45-55. doi: 10.1016/j.jvsv.2018.07.016
- Hartung O, Loundou AD, Barthelemy P, Arnoux D, Boufi M, Alimi YS. Endovascular management of chronic disabling ilio-caval obstructive lesions: long-term results. Eur J Vasc Endovasc Surg. 2009 Jul;38(1):118-24. doi: 10.1016/j.ejvs.2009.03.004
- Rossi FH, Kambara AM, Izukawa NM, Rodrigues TO, Rossi CB, Sousa AG, Metzger PB, Thorpe PE. Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):183-91. doi: 10.1016/j.jvsv.2017.11.003
- Sarici IS, Yanar F, Agcaoglu O, Ucar A, Poyanli A, Cakir S, Aksoy SM, Kurtoglu M. Our early experience with iliofemoral vein stenting in patients with post-thrombotic syndrome. Phlebology. 2014 Jun;29(5):298-303. doi: 10.1177/0268355513477641
- Gavrilov SG. Combination of May-Thurner syndrome and pelvic congestion syndrome: terra incognita. Phlebolymphology. 2021;28(3):90-102. https://www.phlebolymphology.org/wp-content/uploads/2022/01/Phlebolymphology-105.pdf
- Raju S, Owen S Jr, Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg. 2002 Jan;35(1):8-15. doi: 10.1067/mva.2002.121054
- van Vuuren TMAJ, Doganci S, Wittens CHA. Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent. J Vasc Surg Venous Lymphat Disord. 2018 May;6(3):321-29. doi: 10.1016/j.jvsv.2017.09.013
- Lichtenberg M, Breuckmann F, Stahlhoff WF, Neglén P, Rick G. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes. Vasa. 2018 Oct;47(6):475-81. doi: 10.1024/0301-1526/a000731
- Oguzkurt L, Tercan F, Ozkan U, Gulcan O. Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up. Eur J Radiol. 2008 Dec;68(3):487-92. doi: 10.1016/j.ejrad.2007.08.019
- Santoshi RKN, Lakhanpal S, Satwah V, Lakhanpal G, Malone M, Pappas PJ. Iliac vein stenosis is an underdiagnosed cause of pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):202-211. doi: 10.1016/j.jvsv.2017.09.007
- Lakhanpal G, Kennedy R, Lakhanpal S, Sulakvelidze L, Pappas PJ. Pelvic venous insufficiency secondary to iliac vein stenosis and ovarian vein reflux treated with iliac vein stenting alone. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1193-98. doi: 10.1016/j.jvsv.2021.03.006
- Daugherty SF, Gillespie DL. Venous angioplasty and stenting improve pelvic congestion syndrome caused by venous outflow obstruction. J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):283-89. doi: 10.1016/j.jvsv.2015.01.003
- Tangney E, O’Donnell T, Iafrati M. Cost and Benefit Analysis of Stenting Versus Compression Therapy for Patients With Chronic Total Venous Occlusion. J Vasc Surg Venous Lymphat Disord. 2016;4(1):137. doi: 10.1016/j.jvsv.2015.10.014
119049, Russian Federation,
Moscow, Leninsky prospect, 10, 5,
tel. 8 916 929 99 47,
e-mail: gavriloffsg@mail.ru,
Sergey G. Gavrilov
Gavrilov Sergey G., MD, Professor, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
http://orcid.org/0000-0002-2307-2176
Lebedev Igor S., MD, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0001-7956-3807
Vasiliev Alexey V., Internetional Surgeon, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
Mishakina Nadezhda Y., Ultrasound Diagnostics Doctor, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0002-3626-0299